Comparative analysis of antibiotics: Inhibition of protein synthesis versus DNA synthesis

In this piece of writing, we will be addressing the following factors: properties of antibiotics, mechanism of action, clinical safety profile, as well as toxicity, adverse event profile, and case fatality rate. From our evaluation, in terms of properties of the two groups of antibiotics, protein synthesis-inhibiting antibiotics displays a like number of lipophilic and hydrophilic properties, with the majority of Anti-30S inhibitor drugs being predominantly hydrophilic, and a higher number of lipophilic drugs amongst Anti-50S inhibitors. Anti-50S inhibitors could therefore be preferred in oral intake drug development. DNA synthesis-inhibiting antibiotics show a limited trend in their properties. The mechanism of action for protein synthesis-inhibiting antibiotics generally follows four steps: activation of amino acids, initiation, extension, and termination of peptide chain synthesis. On the other hand, DNA synthesis-inhibiting antibiotics exhibits a range of different mechanisms, all of which results in the damage of DNA structure of the bacterium. In both clinical safety and toxicity studies, it is concluded that the two groups of antibiotics have previous cases of side effects, with the DNA synthesis-inhibiting drug, fluoroquinolones, more dangerous due to its potential to result in ventricular fibrillation on a patient. By assessing and comparing all the factors, this review aims to present a precise comparison of the similarities and differences between the protein and DNA synthesis inhibitors, and an evaluation of the effectiveness of the two groups against bacterial infections, along with their safety for regular medication use.